Listed

Graftech International Ltd: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Jul 31, 2019 and accepted by EDGAR at Jul 31, 2019, 16:36 ET.

Share

Management's discussion and analysis

As filed, 45,008 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Outlook

GrafTech is a leading manufacturer of graphite electrodes, the critical consumable for the electric arc furnace ("EAF") industry. We are the only graphite electrode producer that is substantially vertically integrated into petroleum needle coke, the key raw material for graphite electrodes. Vertical integration has allowed us to adopt a commercial strategy with long-term, fixed price, fixed volume, take-or-pay contracts providing earnings stability and visibility. These contracts define volumes and prices, along with price‑escalation mechanisms for inflation, and include significant termination payments (typically, 50% to 70% of remaining contracted revenue) and, in certain cases, parent guarantees and collateral arrangements to manage our customer credit risk. We have entered into three‑to‑five‑year take‑or‑pay contracts to sell approximately 148,000, 145,000, 128,000 and 120,000 metric tons ("MT") in 2019, 2020, 2021 and 2022, respectively. We have contracted approximately 65-70% of our production capacity through these contracts.

Our weighted average realized price of GrafTech manufactured electrodes was $10,014 per MT in the second quarter of 2019 compared to $9,783 per MT in the second quarter of 2018, which has been recast as described below. While spot prices have come down from recent historic highs, they still remain well above their historical average. Strong economics for the EAF producers that we serve has led to EAF production since 2016 resuming growth in line with its historical trend (2.8% annually from 1984-2017). Steelmakers have announced EAF capacity expansions representing a potential 15 to 20% increase in graphite electrode demand in the U.S. by 2022. However, near-term steel production growth has slowed in several key regions, most notably Europe.

A tight needle coke market is also contributing to these elevated prices. Needle coke demand from electric vehicle batteries is currently disrupting the supply chain and resulting in increased pricing and higher costs of sales. Although our vertical integration largely protects us from the increase in needle coke costs, we expect to purchase approximately one third of our needle coke supply from third parties. These higher needle coke costs will continue to impact our earnings.

We are impacted in varying degrees, both positively and negatively, as global, regional or country economic conditions fluctuate. Our discussions about market data and global economic conditions below are derived from published industry accounts and statistics. In its July 2019 report, the International Monetary Fund ("IMF") reported that they were again lowering their growth forecast by 0.1% for both 2019 and 2020. This was driven by increased tariff activity, current GDP reports and softening inflation pointing to weaker-than-anticipated global activity. The IMF now estimates the global growth rate for 2019 at 3.2% and 3.5% for 2020.

Graphite electrode demand is primarily linked to the global production of steel in electric arc furnaces, and to a lesser extent, with the total production of steel and certain other metals. The World Steel Association's ("WSA") April 2019 Short Range Outlook estimated global steel demand outside of China increased by 2.2% in 2018. WSA decreased their growth forecast for steel demand outside of China for 2019 from 2.7% to 1.7% due to a slowing global economy and a deteriorating trade environment. Year-to-date steel production growth in North America, the Middle East and Africa has been offset by softening in Europe and South America. WSA's growth forecast for steel demand outside of China for 2020 is 2.8%.

Key metrics used by management to measure performance

In addition to measures of financial performance presented in our Condensed Consolidated Financial Statements in accordance with GAAP, we use certain other financial measures and operating metrics to analyze the performance of our company. The “non‑GAAP” financial measures consist of EBITDA from continuing operations and adjusted EBITDA from continuing operations, which help us evaluate growth trends, establish budgets, assess operational efficiencies and evaluate our overall financial performance. The key operating metrics consist of sales volume, weighted average realized price, production volume, production capacity and capacity utilization.

Key financial measures

(in thousands)

For the Three Months Ended June 30, 2019 2018 For the Six Months Ended June 30, 2019 2018
Net sales $480,390 $456,332 $955,384 $908,231
Net income 196,368 201,448 393,804 425,121
EBITDA from continuing operations(1) 281,818 228,143 560,543 532,911
Adjusted EBITDA from continuing operations(1) 284,404 291,956 568,219 602,295

24

(1) See below for information and a reconciliation of EBITDA and adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP.

Key operating metrics

In an effort to improve transparency, beginning in the first quarter of 2019, we recast the key operating metrics of sales volume and weighted average realized price per metric ton as set forth in the table below to include only graphite electrodes manufactured by GrafTech. This better reflects management’s assessment of our revenue and profitability and excludes re-sales of low grade graphite electrodes manufactured by third-party suppliers. For comparability purposes, the prior periods have been recast to conform to this presentation.

(in thousands, except price data)

For the Three Months Ended June 30, 2019 2018 For the Six Months Ended June 30, 2019 2018
Sales volume (MT)(1) 45 42 90 84
Weighted average realized price(2) $10,014 $9,783 $9,984 $9,885
Production volume (MT)(3) 48 45 95 88
Production capacity excluding St. Marys during idle period (MT)(4)(5) 51 45 102 89
Capacity utilization excluding St. Marys during idle period(4)(6) 94% 100% 93% 99%
Total production capacity (MT)(5)(7) 58 52 116 103
Total capacity utilization(6)(7) 83% 87% 82% 85%

(1) Sales volume has been recast to reflect the total sales volume of GrafTech manufactured electrodes for which revenue has been recognized during the period. For additional information see "Key Operating Metrics" below.

(2) Weighted average realized price has been recast to reflect the total revenues from sales of GrafTech manufactured electrodes for the period divided by the GrafTech manufactured electrode volume for that period. For additional information see "Key Operating Metrics" below.

(3) Production volume reflects graphite electrodes we produced during the period.

(4) The St. Marys, Pennsylvania facility was temporarily idled effective the second quarter of 2016 except for the machining of semi‑finished products sourced from other plants. In the first quarter of 2018, our St. Marys facility began graphitizing a limited amount of electrodes sourced from our Monterrey, Mexico facility.

(5) Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance outage. Actual production may vary.

(6) Capacity utilization reflects production volume as a percentage of production capacity.

(7) Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; Pamplona, Spain and St. Marys, Pennsylvania.

Non‑GAAP financial measures

In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA from continuing operations and adjusted EBITDA from continuing operations are non‑GAAP financial measures. We define EBITDA from continuing operations, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes, discontinued operations and depreciation and amortization from continuing operations. We define adjusted EBITDA from continuing operations as EBITDA from continuing operations plus any pension and other post-employment benefit ("OPEB") plan expenses, initial and follow-on public offering expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, related party Tax Receivable Agreement expense, stock-based compensation and non‑cash fixed asset write‑offs. Adjusted EBITDA from continuing operations is the primary metric used by our management and our board of directors to establish budgets and operational goals for managing our business and evaluating our performance.

We monitor adjusted EBITDA from continuing operations as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA from continuing operations and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities.

Our use of adjusted EBITDA from continuing operations has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

  • adjusted EBITDA from continuing operations does not reflect changes in, or cash requirements for, our working capital needs;
  • adjusted EBITDA from continuing operations does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
  • adjusted EBITDA from continuing operations does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
  • adjusted EBITDA from continuing operations does not reflect tax payments that may represent a reduction in cash available to us;
  • adjusted EBITDA from continuing operations does not reflect expenses relating to our pension and OPEB plans;
  • adjusted EBITDA from continuing operations does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar;
  • adjusted EBITDA from continuing operations does not reflect initial and follow-on public offering expenses;
  • adjusted EBITDA from continuing operations does not reflect related party Tax Receivable Agreement expense;
  • adjusted EBITDA from continuing operations does not reflect stock-based compensation or the non‑cash write‑off of fixed assets; and
  • other companies, including companies in our industry, may calculate EBITDA from continuing operations and adjusted EBITDA from continuing operations differently, which reduces its usefulness as a comparative measure.

In evaluating EBITDA from continuing operations and adjusted EBITDA from continuing operations, you should be aware that in the future, we will incur expenses similar to the adjustments in this presentation. Our presentations of EBITDA from continuing operations and adjusted EBITDA from continuing operations should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA from continuing operations and adjusted EBITDA from continuing operations alongside other financial performance measures, including our net income (loss) and other GAAP measures.

The following table reconciles our non‑GAAP key financial measures to the most directly comparable GAAP measures:

(in thousands)

For the Three Months Ended June 30, 2019 2018 For the Six Months Ended June 30, 2019 2018
Net income 196,368 201,448 393,804 425,121
Add:
Discontinued operations — 315 — (1,311)
Depreciation and amortization 15,445 15,368 31,030 31,696
Interest expense 32,969 28,667 66,669 66,532
Interest income (731) (391) (1,145) (506)
Income taxes 37,767 (17,264) 70,185 11,379
EBITDA from continuing operations 281,818 228,143 560,543 532,911
Adjustments:
Pension and OPEB plan expenses (1) 827 484 1,597 995
Initial and follow-on public offering expenses (2) 610 1,935 1,296 5,122
Non‑cash loss on foreign currency remeasurement (3) 616 (1,650) 1,027 223
Stock-based compensation (4) 570 181 862 181
Non‑cash fixed asset write-off (5) (37) 1,062 2,894 1,062
Related party Tax Receivable Agreement expense (6) — 61,801 — 61,801
Adjusted EBITDA from continuing operations 284,404 291,956 568,219 602,295

(1) Service and interest cost of our OPEB plans. Also includes a mark‑to‑market loss (gain) for plan assets as of December of each year.

(2) Legal, accounting, printing and registration fees associated with the initial and follow-on public offerings.

(3) Non‑cash loss from foreign currency remeasurement of non‑operating liabilities of our non‑U.S. subsidiaries where the functional currency is the U.S. dollar.

(4) Non-cash expense for stock-based compensation grants.

(5) Non‑cash fixed asset write‑off recorded for obsolete manufacturing equipment.

(6) Non-cash expense for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized.

Key Operating Metrics

Key operating metrics consist of sales volume, weighted average realized price, production volume, production capacity and capacity utilization.

Sales volume reflects the total volume of GrafTech manufactured graphite electrodes sold for which revenue has been recognized during the period. Weighted average realized price reflects the total revenues from sales of GrafTech manufactured graphite electrodes for the period divided by the sales volume of the GrafTech manufactured electrodes for that period. Beginning in the first quarter of 2019, sales volume and weighted average realized price are presented excluding re-sales of low-grade graphite electrodes manufactured by third-party suppliers. Sales of these third-party manufactured electrodes are now included in the revenue category of “by-products and other,” which represents a minimal contribution to our profitability. This change aligns these metrics with management's assessment of our revenue performance and profit margin and will help investors understand the factors that drive our profitability. For comparability purposes, the prior period sales volume and weighted average realized price have been recast to conform to this presentation.

Production volume reflects graphite electrodes produced during the period. Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance downtime. Capacity utilization reflects production volume as a percentage of production capacity. Production volume, production capacity and capacity utilization help us understand the efficiency of our production, evaluate cost of sales and consider how to approach our contract initiative.

Results of Operations

The Three Months Ended June 30, 2019 Compared to the Three Months Ended June 30, 2018

The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our Management's Discussion and Analysis ("MD&A"), insignificant changes may be deemed not meaningful and are generally excluded from the discussion.

(Dollars in thousands)

For the Three Months Ended June 30, 2019 2018 Increase/ Decrease % Change
Net sales $480,390 $456,332 $24,058 5%
Cost of sales 197,047 165,910 31,137 19%
Gross profit 283,343 290,422 (7,079) (2)%
Research and development 713 581 132 23%
Selling and administrative expenses 15,394 16,239 (845) (5)%
Operating income 267,236 273,602 (6,366) (2)%
Other expense (income), net 863 (974) 1,837 (189)%
Related party Tax Receivable Agreement expense — 61,801 (61,801) N/A
Interest expense 32,969 28,667 4,302 15%
Interest income (731) (391) (340) 87%
Income from continuing operations before provision for income taxes 234,135 184,499 49,636 27%
Provision for (benefit from) income taxes 37,767 (17,264) 55,031 (319)%
Net income from continuing operations 196,368 201,763 (5,395) (3)%
Loss from discontinued operations, net of tax — (315) 315 (100)%
Net income $196,368 $201,448 $(5,080) (3)%

Net sales. Net sales increased from $456.3 million in the three months ended June 30, 2018 to $480.4 million in the three months ended June 30, 2019. The increase was primarily driven by a 6% increase in sales volume of graphite electrodes. Additionally, the weighted average realized price increased to $10,014 per MT in the three months ended June 30, 2019 compared to $9,783 per MT in the same period of the prior year.

Cost of sales. We experienced increases in cost of sales from $165.9 million in the three months ended June 30, 2018 to $197.0 million in the three months ended June 30, 2019. This increase was primarily the result of sales of inventory that was manufactured using higher priced needle coke.

Selling and administrative expenses. Selling and administrative expenses decreased by $0.8 million, or 5%, from $16.2 million in the three months ended June 30, 2018 to $15.4 million in the three months ended June 30, 2019. This change was primarily due to the $1.3 million of costs related to our public offerings in the three months ended June 30, 2018, which did not occur in the same period of 2019. These savings were partially offset by increases in selling and administrative expenses from increased headcount and ongoing costs of being a public company.

Other expense (income). Other expense (income) increased from $1.0 million of income in the three months ended June 30, 2018 to $0.9 million of expense in the three months ended June 30, 2019, primarily due to disadvantageous non‑cash foreign currency impacts on non‑operating assets and liabilities.

Interest Expense. Interest expense increased from $28.7 million in the three months ended June 30, 2018, to $33.0 million in the three months ended June 30, 2019, primarily due to additional borrowings resulting from the June 2018 First Amendment to the 2018 Credit Agreement.

Provision for income taxes. The following table summarizes the expense for income taxes:

(Dollars in thousands)

For the Three Months Ended June 30, 2019 2018
Tax expense (benefit) $37,767 $(17,264)
Pretax income 234,135 184,499
Effective tax rates 16.1% (9.4)%

The effective tax rate for the three months ended June 30, 2019 was 16.1% This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.

The effective tax rate for the three months ended June 31, 2018 was (9.4)%. This rate rate differs from the current U.S. statutory rate of 21% primarily due to the partial release of a valuation allowance recorded against the deferred tax asset related to U.S. tax attributes and the tax impact of worldwide earnings from various countries taxed at different rates. The recognition of the valuation allowance does not result in or limit the Company's ability to utilize these tax assets in the future.

The tax expense changed from a benefit of $(17.3) million for the quarter ended June 30, 2018 to a tax expense of $37.8 million for the quarter ended June 30, 2019. This change is primarily related the partial release of the valuation allowance recorded in the three months ended June 30, 2018.

The Six Months Ended June 30, 2019 Compared to the Six Months Ended June 30, 2018

The tables presented in our period-over-period comparisons summarize our Condensed Consolidated Statements of Operations and illustrate key financial indicators used to assess the consolidated financial results. Throughout our MD&A, insignificant changes may be deemed not meaningful and are generally excluded from the discussion.

(Dollars in thousands)

For the Six Months Ended June 30, 2019 2018 Increase/ Decrease % Change
Net sales $955,384 $908,231 $47,153 5%
Cost of sales 392,571 311,059 81,512 26%
Gross profit 562,813 597,172 (34,359) (6)%
Research and development 1,350 1,010 340 34%
Selling and administrative expenses 30,620 32,115 (1,495) (5)%
Operating income 530,843 564,047 (33,204) (6)%
Other expense 1,330 1,031 299 29%
Related party Tax Receivable Agreement expense — 61,801 (61,801) N/A
Interest expense 66,669 66,532 137 —%
Interest income (1,145) (506) (639) 126%
Income from continuing operations before provision for income taxes 463,989 435,189 28,800 7%
Provision for income taxes 70,185 11,379 58,806 517%
Net income from continuing operations 393,804 423,810 (30,006) (7)%
Income from discontinued operations, net of tax — 1,311 (1,311) (100)%
Net income $393,804 $425,121 $(31,317) (7)%

Net sales. Net sales increased by $47.2 million, or 5%, from $908.2 million in the six months ended June 30, 2018 to $955.4 million in the six months ended June 30, 2019. This increase was driven by a 7% increase in sales volume in the six months ended June 30, 2019 compared to the same period in 2018, primarily due to the completion of our debottlenecking initiative. The weighted average realized price of GrafTech manufactured graphite electrodes was $9,984 per MT in the six months ended June 30, 2019 and was in line with the $9,885 per MT we realized in the six months ended June 30, 2018.

Cost of sales. Cost of sales increased by $81.5 million, or 26%, from $311.1 million in the six months ended June 30, 2018 to $392.6 million in the six months ended June 30, 2019. This increase was primarily the result of higher input costs for needle coke and higher volumes primarily due to our debottlenecking projects coming online.

Selling and administrative expenses. Selling and administrative expenses decreased by $1.5 million, or 5%, from $32.1 million in the six months ended June 30, 2018 to $30.6 million in the six months ended June 30, 2019. This change was primarily due to the $3.8 million of costs related to our public offerings in the six months ended June 30, 2018, which did not occur in the same period in 2019. These savings were partially offset by increases in selling and administrative expenses from increased headcount and ongoing costs of being a public company.

Other expense (income). Other expense decreased by $0.3 million, or 29%, from $1.0 million in the six months ended June 30, 2018 to $1.3 million in the six months ended June 30, 2019. This decrease was primarily due to advantageous non‑cash foreign currency impacts on non‑operating assets and liabilities.

Interest expense. Interest expense was consistent in the six months ended June 30, 2019 compared to the same period of 2018. In the first quarter of 2018, we redeemed our Senior Notes resulting in accelerated accretion of the fair value adjustment on the Senior Notes of $18.7 million and a premium redemption of $4.8 million. This decrease was offset by increased borrowing costs due to higher levels of debt in the six months ended June 30, 2019.

Provision for income taxes. The following table summarizes the expense for income taxes:

(Dollars in thousands)

For the Six Months Ended June 30, 2019 2018
Tax expense $70,185 $11,379
Pretax income 463,989 435,189
Effective tax rates 15.1% 2.6%

The effective tax rate for the six months ended June 30, 2019 was 15.1%. This rate differs from the U.S. statutory rate of 21% primarily due to worldwide earnings from various countries taxed at different rates.

The effective tax rate for the six months ended June 30, 2018 was 2.6%. This rate differed from the U.S. statutory rate of 21% primarily due to the partial release of a valuation allowance recorded against the deferred tax asset related to U.S. tax attributes and the tax impact of worldwide earnings from various countries taxed at different rates. The recognition of the valuation allowance does not result in or limit the Company's ability to utilize these tax assets in the future.

Tax expense increased from $11.4 million for the six months ended June 30, 2018, to $70.2 million for the six months ended June 30, 2019. This change is primarily due to the partial release, in the second quarter of 2018, of a valuation allowance recorded against the deferred tax asset related to U.S. tax attributes.

Effects of Changes in Currency Exchange Rates

When the currencies of non-U.S. countries in which we have a manufacturing facility decline (or increase) in value relative to the U.S. dollar, this has the effect of reducing (or increasing) the U.S. dollar equivalent cost of sales and other expenses with respect to those facilities. In certain countries in which we have manufacturing facilities, and in certain export markets, we sell in currencies other than the U.S. dollar. Accordingly, when these currencies increase (or decline) in value relative to the U.S. dollar, this has the effect of increasing (or reducing) net sales. The result of these effects is to increase (or decrease) operating profit and net income.

Many of the non-U.S. countries in which we have a manufacturing facility have been subject to significant economic and political changes, which have significantly impacted currency exchange rates. We cannot predict changes in currency exchange rates in the future or whether those changes will have net positive or negative impacts on our net sales, cost of sales or net income.

The impact of these changes in the average exchange rates of other currencies against the U.S. dollar on our net sales was a decrease of $1.0 and $3.8 million for the three and six months ended June 30, 2019, respectively, compared to the same period of 2018. The impact of these changes on our cost of sales was an decrease of $2.9 million and $8.6 million for the three and six months ended June 30, 2019, respectively, compared to the same period of 2018.

We have in the past and may in the future use various financial instruments to manage certain exposures to risks caused by currency exchange rate changes, as described under “Part I, Item 3–Quantitative and Qualitative Disclosures about Market Risk”.

Liquidity and Capital Resources

Our sources of funds have consisted principally of cash flow from operations and debt, including our credit facilities (subject to continued compliance with the financial covenants and representations). Our uses of those funds (other than for operations) have consisted principally of dividends, capital expenditures, scheduled debt repayments, optional debt prepayments, share repurchases and other obligations. Disruptions in the U.S. and international financial markets could adversely affect our liquidity and the cost and availability of financing to us in the future.

We believe that we have adequate liquidity to meet our needs. As of June 30, 2019, we had liquidity of $452.2 million consisting of $246.9 million of availability on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $205.3 million. We had long‑term debt of $1,991.3 million and short‑term debt of $43.5 million as of June 30, 2019. As of December 31, 2018, we had liquidity of $295.4 million consisting of $245.5 million available on our 2018 Revolving Facility (subject to continued compliance with the financial covenants and representations) and cash and cash equivalents of $49.9 million. We had long‑term debt of $2,050.3 million and short‑term debt of $106.3 million as of December 31, 2018.

As of June 30, 2019 and December 31, 2018, $39.0 million and $38.4 million, respectively, of our cash and cash equivalents were located outside of the United States. We repatriate funds from our foreign subsidiaries through dividends. All of our subsidiaries face the customary statutory limitation that distributed dividends do not exceed the amount of retained and current earnings. In addition, for our subsidiary in South Africa, the South Africa Central Bank imposes that certain solvency and liquidity ratios remain above defined levels after the dividend distribution, which historically has not materially affected our ability to repatriate cash from this jurisdiction. The cash and cash equivalents balances in South Africa were $2.0 million and $0.2 million as of June 30, 2019 and December 31, 2018, respectively. Upon repatriation to the United States, the foreign source portion of dividends we receive from our foreign subsidiaries is no longer subject to U.S. federal income tax as a result of the Tax Act.

Cash flow and plans to manage liquidity. Our cash flow typically fluctuates significantly between quarters due to various factors. These factors include customer order patterns, fluctuations in working capital requirements, timing of tax payments, timing of capital expenditures, acquisitions, divestitures and other factors. Cash flow from operations is expected to remain at positive sustained levels due to the predictable earnings generated by our three-to-five-year sales contracts with our customers.

As of June 30, 2019 and December 31, 2018, we had access to the $250 million 2018 Revolving Facility. We had $3.1 million of letters of credit, for a total availability on the 2018 Revolving Facility of $246.9 million. We also had $1.6 million of surety bonds outstanding as of June 30, 2019 and $0.5 million as of December 31, 2018.

On February 12, 2018, we entered into the 2018 Credit Agreement, which provides for the 2018 Revolving Facility and the 2018 Term Loan Facility. On February 12, 2018, our wholly owned subsidiary, GrafTech Finance, borrowed $1,500 million under the 2018 Term Loan Facility. The funds received were used to pay off our outstanding debt, including borrowings under our Old Credit Agreement and the Senior Notes and accrued interest relating to those borrowings and the Senior Notes, declare and pay a dividend of $1,112.0 million to our sole pre-IPO stockholder, pay fees and expenses incurred in connection therewith and for other general corporate purposes.

On April 19, 2018, we declared a dividend in the form of the Brookfield Promissory Note to the sole pre-IPO stockholder. The $750 million Brookfield Promissory Note was conditioned upon (i) the Senior Secured First Lien Net Leverage Ratio (as defined in the 2018 Credit Agreement), as calculated based on our final financial results for the first quarter of 2018, being equal to or less than 1.75 to 1.00, (ii) no Default or Event of Default (each as defined in the 2018 Credit Agreement) having occurred and continuing or that would result from the $750 million Brookfield Promissory Note and (iii) the satisfaction of the conditions described in (i) and (ii) above occurring within 60 days from the dividend record date. Upon publication of our first quarter report on Form 10-Q, these conditions were met and, as a result, the Brookfield Promissory Note became payable.

The Brookfield Promissory Note had a maturity of eight years from the date of issuance and bore interest at a rate equal to the Adjusted LIBO Rate (as defined in the Brookfield Promissory Note) plus an applicable margin equal to 4.50% per annum, with an additional 2.00% per annum starting from the third anniversary from the date of issuance. We were permitted to make voluntary prepayments at any time without premium or penalty. All obligations under the Brookfield Promissory Note were unsecured and guaranteed by all of our existing and future domestic wholly owned subsidiaries that guarantee, or are borrowers under, the Senior Secured Credit Facilities. No funds were lent or otherwise contributed to us by Brookfield in connection with the Brookfield Promissory Note. As a result, we received no consideration in connection with its issuance. As described below, the Brookfield Promissory Note was repaid, in full, on June 15, 2018.

On April 19, 2018, we declared a $160 million cash dividend payable to Brookfield, the sole pre-IPO stockholder. Payment of this dividend was conditional upon (i) the Senior Secured First Lien Net Leverage Ratio (as defined in the 2018 Credit Agreement), as calculated based on our final financial results for the first quarter of 2018, being equal to or less than 1.75 to 1.00, (ii) no Default or Event of Default (as defined in the 2018 Credit Agreement) having occurred and continuing or that would result from the payment of the dividend and (iii) the payment occurring within 60 days from the dividend record date. The conditions of this dividend were met upon filing of our first quarter 2018 report on Form 10-Q and the dividend was paid on May 8, 2018.

On June 15, 2018, GrafTech entered into the First Amendment to its 2018 Credit Agreement. The First Amendment amends the 2018 Credit Agreement to provide for the additional $750 million in aggregate principal amount of the Incremental Term Loans to GrafTech Finance. The Incremental Term Loans increase the aggregate principal amount of term loans incurred by GrafTech Finance under the 2018 Credit Agreement from $1,500 million to $2,250 million. The Incremental Term Loans have the same terms as those applicable to the existing term loans under the 2018 Credit Agreement, including interest rate, payment and prepayment terms, representations and warranties and covenants. The Incremental Term Loans mature on February 12, 2025, the same date as the existing term loans. GrafTech paid an upfront fee of 1.00% of the aggregate principal amount of the Incremental Term Loans on the effective date of the First Amendment. The proceeds of the Incremental Term Loans were used to repay, in full, the $750 million in principal outstanding on the Brookfield Promissory Note.

On August 13, 2018, the Company repurchased 11,688,311 shares directly from Brookfield. These shares were retired upon repurchase. The price per share paid by the Company was equal to the price at which the underwriters purchased the shares from Brookfield in Brookfield’s August 2018 public secondary offering of 23,000,000 shares of our common stock, net of underwriting commissions and discounts. GrafTech funded the share repurchase from cash on hand.

On July 30, 2019, our Board of Directors authorized a program to repurchase up to $100 million of our outstanding common stock. We may purchase shares from time to time on the open market, including under Rule 10b5-1 and/or Rule 10b-18 plans. The amount and timing of repurchases are subject to a variety of factors including liquidity, stock price, applicable legal requirements, other business objectives and market conditions.

We currently pay a quarterly cash dividend of $0.085 per share, or an aggregate of $0.34 per share on an annualized basis. Additionally, on December 31, 2018, we paid a special dividend of $0.70 per share totaling $203.4 million. There can be no assurance that we will pay dividends in the future in these amounts or at all. Our Board of Directors may change the timing and amount of any future dividend payments or eliminate the payment of future dividends in its sole discretion, without any prior notice to our stockholders. Our ability to pay dividends will depend upon many factors, including our financial position and liquidity, results of operations, legal requirements, restrictions that may be imposed by the terms of our current and future credit facilities and other debt obligations and other factors deemed relevant by our Board of Directors.

On February 13, 2019, we repaid $125 million on our 2018 Term Loan Facility. We are targeting to return approximately 50-60% of our cash flow after capital expenditures to stockholders in 2019 with the remainder to be used for debt repayment. During the six months ended June 30, 2019, we paid $74.8 million to various tax collecting agencies worldwide.

Potential uses of our liquidity include dividends, share repurchases, capital expenditures, acquisitions, scheduled debt repayments, optional debt prepayments and other general purposes. An improving economy, while resulting in improved results of operations, could increase our cash requirements to purchase inventories, make capital expenditures and fund payables and other obligations until increased accounts receivable are converted into cash. A downturn could significantly and negatively impact our results of operations and cash flows, which, coupled with increased borrowings, could negatively impact our credit ratings, our ability to comply with debt covenants, our ability to secure additional financing and the cost of such financing, if available.

In order to seek to minimize our credit risks, we may reduce our sales of, or refuse to sell (except for cash on delivery or under letters of credit or parent guarantees), our products to some customers and potential customers. Our unrecovered trade receivables worldwide have not been material during the last two years individually or in the aggregate.

We manage our capital expenditures by taking into account quality, plant reliability, safety, environmental and regulatory requirements, prudent or essential maintenance requirements, global economic conditions, available capital resources, liquidity, long‑term business strategy and return on invested capital for the relevant expenditures, cost of capital and return on invested capital of the Company as a whole and other factors.

In the event that operating cash flows fail to provide sufficient liquidity to meet our business needs, including capital expenditures, any such shortfall would need to be made up by increased borrowings under our 2018 Revolving Facility, to the extent available.

Cash Flows

The following table summarizes our cash flow activities:

in millions

Cash flow provided by (used in): For the Six Months Ended June 30, 2019 2018
Operating activities $359.0 $377.7
Investing activities $(29.1) $(27.9)
Financing activities $(174.4) $(195.8)

Operating Activities

Cash flow from operating activities represents cash receipts and cash disbursements related to all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net income (loss) for:

  • Non-cash items such as depreciation and amortization, impairment, post retirement obligations, and severance and pension plan changes;
  • Gains and losses attributed to investing and financing activities such as gains and losses on the sale of assets and unrealized currency transaction gains and losses; and
  • Changes in operating assets and liabilities which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations.

The net impact of the changes in working capital (operating assets and liabilities), which are discussed in more detail below, include the impact of changes in: receivables, inventories, prepaid expenses, accounts payable, accrued liabilities, accrued taxes, interest payable, and payments of other current liabilities.

During the six months ended June 30, 2019, changes in working capital resulted in a net use of funds of $102.5 million which was impacted by:

  • net cash outflows in accounts receivable of $65.1 million from the increase in accounts receivable due to the timing of sales and collections, as shipments in the second quarter of 2019 were weighted towards the latter part of the quarter;
  • net cash outflows from increases in inventory of $16.1 million, due primarily to higher priced raw materials;
  • net cash inflows from the utilization of prepaid assets of $3.3 million;
  • net cash outflows from decreased income taxes payable of $27.6 million resulting from required tax payments as our profitability has increased; and
  • net cash inflows from increases in accounts payable and accruals of $2.2 million, due to the timing of payments.

Uses of cash in the six months ended June 30, 2019 included contributions to pension and other benefit plans of $1.6 million, cash paid for interest of $62.8 million and taxes paid of $74.8 million.

During the six months ended June 30, 2018, changes in working capital resulted in a net use of funds of $158.6 million which was impacted by:

  • net cash outflows in accounts receivable of $110.7 million from the increase in accounts receivable due to increased sales driven by higher weighted average realized prices;
  • net cash outflows from increases in inventory of $82.6 million, due primarily to higher priced raw materials;
  • net cash inflows from increases in accounts payable of $21.1 million, due primarily to higher priced raw materials; and
  • net cash inflows from decreased prepaid expense of $8.3 million due to the reduction of advanced payments.
  • net cash inflows from increased interest payable of $5.3 million due to increased borrowings.

Other uses of cash in the six months ended June 30, 2018 included contributions to pension and other benefit plans of $3.7 million, cash paid for interest of $35.2 million and taxes paid of $11.7 million.

Investing Activities

Net cash used investing activities was $29.1 million during the six months ended June 30, 2019, resulting from capital expenditures.

Net cash used investing activities was $27.9 million during the six months ended June 30, 2018 resulting from capital expenditures of $28.7 million partially offset by proceeds from the sale of fixed assets of $0.8 million.

Financing Activities

Net cash outflow from financing activities was $174.4 million during the six months ended June 30, 2019, which was the result of our $125.0 million payment on our long-term debt and $49.4 million of total dividends to stockholders.

Net cash outflow from financing activities was $195.8 million during the six months ended June 30, 2018, which was the net impact of our February 12, 2018 refinancing and subsequent amendment, proceeds of which were used to repay outstanding debt, pay a dividend of $1,291.5 million, and repay the $750 million Brookfield Promissory Note to Brookfield.

Related Party Transactions

We have engaged, from time to time, in transactions with affiliates or related parties and we expect to continue to do so in the future. These transactions include, among others, entry into agreements with Brookfield such as the Stockholder Rights Agreement, the Registration Rights Agreement, the Tax Receivable Agreement and the Share Repurchase Agreement.

We have also reimbursed certain costs incurred by Brookfield as required under the Investment Agreement dated May 4, 2015 between Brookfield and GrafTech, including in connection with, transactions with our current or former subsidiaries, compensatory transactions with directors and officers including employee benefits (including reimbursement to Brookfield for compensation costs incurred by it for certain personnel who devote substantially all of their working time to us), stock option and restricted stock grants, compensation deferral, stock purchases, and customary indemnification and expense advancement arrangements.

Recent Accounting Pronouncements

We discuss recently adopted accounting standards in Note 1, “Organization and Summary of Significant Accounting Policies” of the Notes to Condensed Consolidated Financial Statements.

Description of Our Financing Structure

We discuss our financing structure in more detail in Note 6, “Debt and Liquidity” of the Notes to Condensed Consolidated Financial Statements.

Market risk

As filed, 4,616 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risks, primarily from changes in interest rates, currency exchange rates, energy commodity prices and commercial energy rates. From time to time, we enter into transactions that have been authorized according to documented policies and procedures in order to manage these risks. These transactions relate primarily to financial instruments described below. Since the counterparties to these financial instruments are large commercial banks and similar financial institutions, we do not believe that we are exposed to material counterparty credit risk. We do not use financial instruments for trading purposes.

Our exposure to changes in interest rates results primarily from floating rate long‑term debt tied to LIBOR or Euro LIBOR.

Our exposure to changes in currency exchange rates results primarily from:

  • sales made by our subsidiaries in currencies other than local currencies;
  • raw material purchases made by our foreign subsidiaries in currencies other than local currencies; and
  • investments in and intercompany loans to our foreign subsidiaries and our share of the earnings of those subsidiaries, to the extent denominated in currencies other than the U.S. dollar.

Our exposure to changes in energy commodity prices and commercial energy rates results primarily from the purchase or sale of refined oil products and the purchase of natural gas and electricity for use in our manufacturing operations.

Interest rate risk management. We periodically enter into agreements with financial institutions that are intended to limit our exposure to additional interest expense due to increases in variable interest rates. These instruments effectively cap our interest rate exposure. We currently do not have any such instruments outstanding.

Currency rate management. We enter into foreign currency derivatives from time to time to attempt to manage exposure to changes in currency exchange rates. These foreign currency derivatives, which include, but are not limited to, forward exchange contracts and purchased currency options, attempt to hedge global currency exposures. Forward exchange contracts are agreements to exchange different currencies at a specified future date and at a specified rate. Purchased currency options are instruments which give the holder the right, but not the obligation, to exchange different currencies at a specified rate at a specified date or over a range of specified dates. Forward exchange contracts and purchased currency options are carried at market value.

The outstanding foreign currency derivatives represented no net unrealized gain or loss as of June 30, 2019 and December 31, 2018.

Energy commodity management. We have entered into commodity derivative contracts to effectively fix some or all of our exposure to refined oil products. The outstanding commodity derivative contracts represented a net unrealized pre-tax gain of $14.2 million and net unrealized pre-tax loss of $10.7 million as of June 30, 2019 and December 31, 2018, respectively.

Sensitivity analysis. We use sensitivity analysis to quantify potential impacts that market rate changes may have on the underlying exposures as well as on the fair values of our derivatives. The sensitivity analysis for the derivatives represents the hypothetical changes in value of the hedge position and does not reflect the related gain or loss on the forecasted underlying transaction.

We had no interest rate derivative instruments outstanding as of June 30, 2019. A hypothetical increase in interest rates of 100 basis points (1%) would have increased our interest expense by $10.5 million for the six months ended June 30, 2019.

As of June 30, 2019, a 10% appreciation or depreciation in the value of the U.S. dollar against foreign currencies from the prevailing market rates would result in a corresponding decrease of $4.3 million or a corresponding increase of $4.3 million, respectively, in the fair value of the foreign currency hedge portfolio.

A 10% increase or decrease in the value of the underlying commodity prices that we hedge would result in a corresponding increase or decrease of $12.2 million in the fair value of the commodity hedge portfolio as of June 30, 2019. Because of the high correlation between the hedging instrument and the underlying exposure, fluctuations in the value of the instruments are generally offset by reciprocal changes in the value of the underlying exposure.

For further information related to the financial instruments described above, see Note 11 "Derivative Instruments" to the Consolidated Financial Statements.

Controls and procedures

As filed, 1,698 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures. Management is responsible for establishing and maintaining adequate disclosure controls and procedures at the reasonable assurance level. Disclosure controls and procedures are designed to ensure that information required to be disclosed by a reporting company in the reports that it files or submits under the Section 13 or 15(d) of the Securities and Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by it in the reports that it files under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2019. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these controls and procedures are effective at the reasonable assurance level as of June 30, 2019.

Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2019 that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Risk factors

As filed, 147 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the Risk Factors disclosed in Part I - Item 1A of our Annual Report on Form 10-K filed on February 22, 2019.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$480.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-01-01 to 2019-06-30$955.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-04-01 to 2019-06-30$197.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-01-01 to 2019-06-30$392.6mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-04-01 to 2019-06-30$283.3mus-gaap:GrossProfit
Gross profit6 months2019-01-01 to 2019-06-30$562.8mus-gaap:GrossProfit
Research and development3 months2019-04-01 to 2019-06-30$713.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-01-01 to 2019-06-30$1.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-04-01 to 2019-06-30$15.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-01-01 to 2019-06-30$30.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-04-01 to 2019-06-30$267.2mus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30$530.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$33.0mus-gaap:InterestExpense
Interest expense6 months2019-01-01 to 2019-06-30$66.7mus-gaap:InterestExpense
Income tax3 months2019-04-01 to 2019-06-30$37.8mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-01-01 to 2019-06-30$70.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-04-01 to 2019-06-30$196.4mus-gaap:NetIncomeLoss
Net income6 months2019-01-01 to 2019-06-30$393.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30$0.68us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30$1.36us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-04-01 to 2019-06-30$0.68us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-01-01 to 2019-06-30$1.36us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-04-01 to 2019-06-30290,574,153 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-01-01 to 2019-06-30290,571,132 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-01-01 to 2019-06-30$359.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$29.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2019-01-01 to 2019-06-30$10.4mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2019-06-30$205.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$881.3mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$1.73bnus-gaap:Assets
Current liabilitiesAt period end2019-06-30$260.1mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2019-06-30$1.99bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-06-30$43.5mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2019-06-30$43.5mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2019-06-30−$709.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000931148-19-000031. Last ingested by Listed: Nov 10, 2026, 00:15 ET. Listed shows no prices and gives no investment advice.